PAV-220830FLY-612

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-612

4019-190603

NHP-220830FLY-2

anti-cd4 infusion premed. , Pre-dosing vitals; HR 140, RR 32, T 100.7. Interim vitals; HR 150, RR 32, T 100.8. End of infusion vitals; HR 150, RR 30, T 100.4. No adverse reaction. , anti-cd4 infusion

https://fairdomhub.org/sops/795

Treatment

Not specified

Flynn Lab

2019-06-03 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

445

milligram

Diphenhydramine

Medication

Intramuscularly

10

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 11

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:36

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH